Early Stage Lung Biobank, Canada

Registration Status: Completed

Objective: The purpose of the BC Lung Biobank is to facilitate investigation of the cause, development, diagnosis and treatment of lung diseases. Samples and their linked information will be made available to researchers who are conducting research projects that aim to improve our overall understanding of these diseases. The samples will be used to investigate lung diseases including genetic (meaning related to genes or hereditary), immunologic (meaning the immune system or the system your body uses to fight disease) and other factors that influence occurrence, response to therapy, and outcomes, as well as act as a resource for internal Biobank research projects.

Registered Biobank Name Early Stage Lung Biobank
Biobank Leader Dr. John Yee
Country Canada
Email for biobank inquiries richard.xiang@vch.ca
Principal Investigator Dr. Anna McGuire
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: